These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12387658)

  • 1. Homocysteine and coronary heart disease: how great is the hazard?
    Wilson PW
    JAMA; 2002 Oct 23-30; 288(16):2042-3. PubMed ID: 12387658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
    Blankenberg S; Rupprecht HJ; Peetz D; Bickel C; Hofman KP; Tiret L; Meyer J
    Dtsch Med Wochenschr; 2002 Apr; 127(14):729-35. PubMed ID: 11935469
    [No Abstract]   [Full Text] [Related]  

  • 3. Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction.
    Virgos C; Joven J; Simó JM; Vilella E; Camps J; Arcelus R; Blanco-Vaca F; Figuera L; Martorell L
    Clin Biochem; 2000 Aug; 33(6):509-12. PubMed ID: 11074245
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
    Wilcken DE; Wang XL; Wilcken B
    Circulation; 1997 Oct; 96(8):2738-40. PubMed ID: 9355925
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population.
    Araújo F; Lopes M; Gonçalves L; Maciel MJ; Cunha-Ribeiro LM
    Thromb Haemost; 2000 Mar; 83(3):517-8. PubMed ID: 10744169
    [No Abstract]   [Full Text] [Related]  

  • 6. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.
    Gallagher PM; Meleady R; Shields DC; Tan KS; McMaster D; Rozen R; Evans A; Graham IM; Whitehead AS
    Circulation; 1996 Nov; 94(9):2154-8. PubMed ID: 8901666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum homocysteine, folate and thermolabile variant of MTHFR in healthy Sri Lankans living in London.
    Alagratnam D; Wierzbicki AS; Swaminathan R; Turner C; Wickramasinghe SN
    Atherosclerosis; 2000 Mar; 149(1):221-2. PubMed ID: 10799015
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylenetetrahydrofolate reductase mutation and coronary artery disease.
    Samani NJ
    Circulation; 1998 Dec 22-29; 98(25):2932-3. PubMed ID: 9860798
    [No Abstract]   [Full Text] [Related]  

  • 9. Differing relationships of methylene tetrahydrofolate reductase genotypes with cardiovascular risk in familial and polygenic hypercholesterolaemia.
    Wierzbicki AS; Lambert-Hammill M; Junadi E; Lumb PJ; Crook MA
    J Cardiovasc Risk; 2000 Dec; 7(6):431-4. PubMed ID: 11155296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
    Klerk M; Verhoef P; Clarke R; Blom HJ; Kok FJ; Schouten EG;
    JAMA; 2002 Oct 23-30; 288(16):2023-31. PubMed ID: 12387655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of folic acid on homocysteine in persons classified by methylenetetrahydrofolate reductase genotype.
    Duell PB; Malinow MR
    Am J Clin Nutr; 1999 Jun; 69(6):1287-9. PubMed ID: 10357752
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia.
    Mager A; Battler A; Birnbaum Y; Magal N; Shohat M
    Am J Cardiol; 2002 Apr; 89(8):919-23. PubMed ID: 11950428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase mutation and coronary artery disease.
    Narang R; Callaghan G; Haider AW; Davies GJ; Tuddenham EG
    Circulation; 1996 Nov; 94(9):2322-3. PubMed ID: 8901706
    [No Abstract]   [Full Text] [Related]  

  • 15. Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease.
    Brattström L
    Circulation; 1997 Nov; 96(10):3805-7. PubMed ID: 9396508
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
    Rozen R
    Thromb Haemost; 1997 Jul; 78(1):523-6. PubMed ID: 9198208
    [No Abstract]   [Full Text] [Related]  

  • 17. The homocysteine confusion: now, more is better?
    Canavese C; Messuerotti A; Fenoglio R; Mesiano P; Massarenti P; Pauletto D; Aimo G; Priolo G
    Kidney Int; 2002 May; 61(5):1907-8; author reply 1908-9. PubMed ID: 11967046
    [No Abstract]   [Full Text] [Related]  

  • 18. [Genetic polymorphisms of methylenetetrahydrofolate reductase and methionine synthase: association with homocysteine metabolism and late-onset vascular diseases in the Japanese population].
    Morita H; Kurihara H; Sugiyama T; Kitamura K; Suzuki S; Sumiyoshi T; Yazaki Y
    J Cardiol; 1999 Feb; 33(2):106-7. PubMed ID: 10087483
    [No Abstract]   [Full Text] [Related]  

  • 19. Homocysteine and cardiovascular risk.
    Scott JM
    Am J Clin Nutr; 2000 Aug; 72(2):333-4. PubMed ID: 10919922
    [No Abstract]   [Full Text] [Related]  

  • 20. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease.
    Kluijtmans LA; Kastelein JJ; Lindemans J; Boers GH; Heil SG; Bruschke AV; Jukema JW; van den Heuvel LP; Trijbels FJ; Boerma GJ; Verheugt FW; Willems F; Blom HJ
    Circulation; 1997 Oct; 96(8):2573-7. PubMed ID: 9355896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.